» Articles » PMID: 15734900

Comparison of the Antinociceptive Profiles of Gabapentin and 3-methylgabapentin in Rat Models of Acute and Persistent Pain: Implications for Mechanism of Action

Overview
Specialty Pharmacology
Date 2005 Mar 1
PMID 15734900
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The anticonvulsant gabapentin (GBP) has been shown effective for the treatment of neuropathic pain, although its mechanism of action remains unclear. A recent report has suggested that binding to the alpha(2)delta subunit of voltage-gated calcium channels contributes to its antinociceptive effect, based on the stereoselective efficacy of two analogs: (1S,3R)3-methylgabapentin (3-MeGBP) (IC(50) = 42 nM), which is effective in neuropathic pain models; and (1R,3R)3-MeGBP (IC(50) > 10,000 nM), which is ineffective (Field et al., 2000). The present study was designed to further examine the profiles of GBP and 3-MeGBP in rat models of acute and persistent pain. Systemic administration of GBP or (1S,3R)3-MeGBP inhibited tactile allodynia in the spinal nerve ligation model of neuropathic pain, whereas (1R,3R)3-MeGBP was ineffective. The antiallodynic effect of GBP, but not (1S,3R)3-MeGBP, was blocked by i.t. injection of the GABA(B) receptor antagonist [3-[[(3,4-dichlorophenyl)methyl]amino]propyl](diethoxymethyl)phosphinic acid (CGP52432). Systemic GBP or (1S,3R)3-MeGBP also inhibited the second phase of formalin-evoked nociceptive behaviors, whereas (1R,3R)3-MeGBP was ineffective. However, both (1S,3R)3-MeGBP and (1R,3R)3-MeGBP, but not GBP, inhibited first phase behaviors. In the carrageenan model of inflammatory pain, systemic GBP or (1R,3R)3-MeGBP failed to inhibit thermal hyperalgesia, whereas (1S,3R)3-MeGBP had a significant, albeit transient, effect. Systemic (1S,3R)3-MeGBP, but not GBP or (1R,3R)3-MeGBP, also produced an antinociceptive effect in the warm water tail withdrawal test of acute pain. These data demonstrate that GBP and 3-MeGBP display different antinociceptive profiles, suggesting dissimilar mechanisms of antinociceptive action. Thus, the stereoselective efficacy of 3-MeGBP, presumably related to alpha(2)delta binding, likely does not completely account for the mechanism of action of GBP.

Citing Articles

TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Busserolles J, Ben Soussia I, Pouchol L, Marie N, Meleine M, Devilliers M Br J Pharmacol. 2020; 177(20):4782-4795.

PMID: 32851651 PMC: 7520446. DOI: 10.1111/bph.15243.


Suppressive Effects of Bee Venom-Derived Phospholipase A2 on Mechanical Allodynia in a Rat Model of Neuropathic Pain.

Woo S, Chung G, Bae H, Kim S Toxins (Basel). 2019; 11(8).

PMID: 31430923 PMC: 6723753. DOI: 10.3390/toxins11080477.


Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease.

Sadler K, Langer S, Menzel A, Moehring F, Erb A, Brandow A Br J Haematol. 2019; 187(2):246-260.

PMID: 31247672 PMC: 6786911. DOI: 10.1111/bjh.16067.


α2δ-1-Bound N-Methyl-D-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents.

Deng M, Chen S, Chen H, Pan H Anesthesiology. 2019; 130(5):804-819.

PMID: 30839350 PMC: 6469992. DOI: 10.1097/ALN.0000000000002648.


Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.

Smith M, Woodhead J, Handy L, Pruess T, Vanegas F, Grussendorf E Neurochem Res. 2017; 42(7):1995-2010.

PMID: 28508174 DOI: 10.1007/s11064-017-2286-9.